Certificate of Analysis

* For quality assurance purposes. Not a Maine compliance certificate.

Square One Natural Relief CBD Lotion (Topical)

Produced: Dec 04, 2025

Client: Square One, LLC // Batch Result: Passed

Img

Matrix: Topical 1

Sample ID: NAL-251203-005

Collected On: Dec 03, 2025

Received On: Dec 03, 2025

Sample Size: 120 ml 1

Sampled By: Bobbie W. Stormann

Received By: CJ Langley

1 Entered By Client

CBD

0.412 %

0.412 %

CBC

0.000 %

0.000 %

Total Cannabinoids

0.412 %

0.412 %

Manufacturer

Square One LLC

License

AM1161

Type

Adult-Use - Manufacturing License

Authorized By:

Zachary Smith

Laboratory Manager, Nova Analytic Labs

Dec 04, 2025

Signature

Nova Analytic Labs // 65 Milliken Street, Unit C Portland ME 04103 // PH: 2074664661

Email: innovation@nova-analyticlabs.com

ME License #: TF284

https://lims.tagleaf.com/coa_/gkDkHwDey3

CAN.1: Potency & Cannabinoid Profile by HPLC-UV

Preparation: Dec 03, 2025

Analysis: Dec 03, 2025

Reported on an as received basis.
1000 µg/g = 1 mg/g

Analyte Detected Pass/Fail
CBC ND N/A
CBCA ND N/A
CBD 0.412 % N/A
CBDA ND N/A
CBDV ND N/A
CBDVA ND N/A
CBG ND N/A
CBGA ND N/A
CBL ND N/A
CBLA ND N/A
CBN ND N/A
CBNA ND N/A
Δ8-THC ND N/A
Δ8-THCA ND N/A
Δ9-THC ND N/A
Δ10-THC ND N/A
Exo-THC ND N/A
THCA ND N/A
THCV ND N/A
THCVA ND N/A
Total THC
(Total THC = (THCA x 0.877) + Delta-9-THC)
ND N/A
Total CBD
(Total CBD = (CBDA x 0.877) + CBD)
0.412 % N/A
Notes

Zachary Smith

Dec 04, 2025

Potency & Cannabinoid Profile by HPLC-UV

The standard lab uncertainty for potency is 5% of the reported value.

Product Images

* For quality assurance purposes. Not a Maine compliance certificate.

ALL TESTS WERE PERFORMED IN ACCORDANCE WITH THE RULES AND REGULATIONS SET FORTH IN THE MAINE ADULT USE PROGRAM. LABORATORY SAMPLING PROTOCOLS ARE GOVERNED BY THE OCP'S SAMPLING GUIDANCE DOCUMENTS. ALL INFORMATION PROVIDED BY THE CLIENT, INCLUDING SELF SAMPLING, MUST BE ACCURATE AND ADHERE TO THE SAME RULES AND REGULATIONS. HOWEVER, CLIENT PROVIDED INFORMATION, INCLUDING SAMPLING, IS ULTIMATELY THE RESPONSIBILITY OF THE PROVIDING LICENSEE, REGISTERED CAREGIVER, PATIENT OR THE LIKE AND FAILURE TO FOLLOW SAID PROTOCOLS COULD LEAD TO ERRONEOUS TEST RESULTS. NOTE: NOT ALL POTENTIAL AND/OR EXISTING HAZARDS WERE ANALYZED. THIS CERTIFICATE OF ANALYSIS IS RELEVANT ONLY TO THOSE ITEMS TESTED. THE SAMPLE WAS PROVIDED TO THE LABORATORY FOR TESTING BY THE CLIENT AND THE SAMPLE WAS TESTED AS RECEIVED.

End of Report